University of Tübingen
Dr. Oliver Planz is Professor and head of the group “Translational Immunology of Infection” in the Department of Immunology at the University of University of Tübingen, Germany. He completed his PhD from Institute of Virology, University Giessen. His area of interest mainly focuses on microbiology, immunology and virology.
My research interest is the treatment of influenza with compounds inhibiting cellular targets are a prerequisite for viral did replication. These compounds can Either used as single drugs or in combination with existing anti-viral drugs like oseltamivir. In the areas of disease prevention and treatment, the use of existing drugs in combination has become important to complement to the continued development of new therapeutic agents. Hyperactivation of the Ras-dependent Raf / MEK / ERK mitogen-activated protein kinase (MAPK) signaling pathway is frequently Observed in human malignancies. Components of the MAPK pathway are viewed as attractive candidates for the development of targeted therapies of cancer. Substances inhibiting MEK are in a current state of clinical evaluation in cancer.